BioCryst Pharmaceuticals, Inc. (BCRX)

Exchange NASDAQ
10.88


Currency in USD (Disclaimer)
Volume:
Day's Range:

BCRX Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-07 SANDERS MACHELLE director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 SANDERS MACHELLE director 12,866.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 MILANO VINCENT director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 MILANO VINCENT director 30,366.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 INGRAM ROBERT ALEXANDER director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 INGRAM ROBERT ALEXANDER director 95,004.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 McKee Amy E director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 McKee Amy E director 12,866.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 Hutson Nancy J director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 Hutson Nancy J director 77,939.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 HEGGIE THERESA director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 HEGGIE THERESA director 30,229.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 ABERCROMBIE GEORGE B director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 ABERCROMBIE GEORGE B director 12,866.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 LEVIN ALAN G director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 LEVIN ALAN G director 16,063.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 LEE KENNETH B JR director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 LEE KENNETH B JR director 37,118.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 ASELAGE STEVE director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 ASELAGE STEVE director 46,594.0 A-Award A 12,866.0 0.00 0.00
2022-06-07 Galson Steven K director 30,022.0 A-Award A 30,022.0 10.79 323,937.38
2022-06-07 Galson Steven K director 12,866.0 A-Award A 12,866.0 0.00 0.00
2022-05-31 ASELAGE STEVE director 33,728.0 A-Award A 569.0 9.31 5,297.39
2022-05-31 HEGGIE THERESA director 17,363.0 A-Award A 1,138.0 9.31 10,594.78
2022-05-31 LEVIN ALAN G director 3,197.0 A-Award A 1,138.0 9.31 10,594.78
2022-05-31 INGRAM ROBERT ALEXANDER director 82,138.0 A-Award A 2,078.0 9.31 19,346.18
2022-04-18 ABERCROMBIE GEORGE B director 0.0 M-Exempt D 5,000.0 3.32 16,600.00
2022-04-18 ABERCROMBIE GEORGE B director 0.0 S-Sale D 5,000.0 11.04 55,200.00
2022-04-18 ABERCROMBIE GEORGE B director 5,000.0 M-Exempt A 5,000.0 3.32 16,600.00
2022-04-01 Thackray Helen M. officer: Chief R&D Officer 136,400.0 S-Sale D 7,600.0 16.20 123,120.00
2022-03-10 Sheridan William P officer: Chief Medical Officer 0.0 M-Exempt D 148,302.0 3.22 477,532.44
2022-03-10 Sheridan William P officer: Chief Medical Officer 37,954.0 S-Sale D 1,400.0 17.64 24,696.00
2022-03-10 Sheridan William P officer: Chief Medical Officer 39,354.0 S-Sale D 159,739.0 16.87 2,694,796.93
2022-03-10 Sheridan William P officer: Chief Medical Officer 199,093.0 M-Exempt A 148,302.0 3.22 477,532.44
2022-03-07 Babu Yarlagadda S officer: Chief Discovery Officer 230,056.0 S-Sale D 20,000.0 17.16 343,200.00
2022-03-01 Jones Michael L officer: Exec. Director, Finance - PAO 0.0 M-Exempt D 2,300.0 4.73 10,879.00
2022-03-01 Jones Michael L officer: Exec. Director, Finance - PAO 11,198.0 S-Sale D 2,300.0 17.20 39,560.00
2022-03-01 Jones Michael L officer: Exec. Director, Finance - PAO 13,498.0 M-Exempt A 2,300.0 4.73 10,879.00
2022-02-28 ASELAGE STEVE director 33,159.0 A-Award A 301.0 16.61 4,999.61
2022-02-28 HEGGIE THERESA director 16,225.0 A-Award A 602.0 16.61 9,999.22
2022-02-28 INGRAM ROBERT ALEXANDER director 80,060.0 A-Award A 1,128.0 16.61 18,736.08
2022-02-28 LEVIN ALAN G director 2,059.0 A-Award A 602.0 16.61 9,999.22
2022-02-15 ABERCROMBIE GEORGE B director 5,000.0 M-Exempt D 5,000.0 3.32 16,600.00
2022-02-15 ABERCROMBIE GEORGE B director 0.0 S-Sale D 5,000.0 18.50 92,500.00
2022-02-15 ABERCROMBIE GEORGE B director 5,000.0 M-Exempt D 5,000.0 3.32 16,600.00
2022-02-08 SANDERS MACHELLE director 26,667.0 A-Award A 26,667.0 17.20 458,672.40
2022-01-11 Stonehouse Jon P director, officer: President & CEO 0.0 M-Exempt D 184,000.0 4.73 870,320.00
2022-01-11 Stonehouse Jon P director, officer: President & CEO 901,602.0 S-Sale D 184,000.0 15.04 2,767,360.00
2022-01-11 Stonehouse Jon P director, officer: President & CEO 1,085,602.0 M-Exempt A 184,000.0 4.73 870,320.00
2021-12-14 Barnes Alane P officer: Chief Legal Officer 201,969.0 A-Award A 55,000.0 0.00 0.00
2021-12-14 Gayer Charles K officer: Chief Commercial Officer 216,556.0 A-Award A 80,000.0 0.00 0.00
2021-12-14 Doyle Anthony officer: Chief Financial Officer 168,719.0 A-Award A 75,000.0 0.00 0.00
2021-12-14 Jones Michael L officer: Exec. Director, Finance - PAO 11,700.0 A-Award A 11,700.0 11.43 133,731.00
2021-12-14 Jones Michael L officer: Exec. Director, Finance - PAO 11,198.0 A-Award A 5,850.0 0.00 0.00
2021-12-14 Gayer Charles K officer: Chief Commercial Officer 164,000.0 A-Award A 164,000.0 11.43 1,874,520.00
2021-12-14 Gayer Charles K officer: Chief Commercial Officer 261,556.0 A-Award A 125,000.0 0.00 0.00
2021-12-14 Babu Yarlagadda S officer: Chief Discovery Officer 164,000.0 A-Award A 164,000.0 11.43 1,874,520.00
2021-12-14 Babu Yarlagadda S officer: Chief Discovery Officer 250,056.0 A-Award A 35,000.0 0.00 0.00
2021-12-14 Thackray Helen M. officer: Chief R&D Officer 205,000.0 A-Award A 205,000.0 11.43 2,343,150.00
2021-12-14 Thackray Helen M. officer: Chief R&D Officer 144,000.0 A-Award A 44,000.0 0.00 0.00
2021-12-14 Barnes Alane P officer: Chief Legal Officer 164,000.0 A-Award A 164,000.0 11.43 1,874,520.00
2021-12-14 Barnes Alane P officer: Chief Legal Officer 221,969.0 A-Award A 75,000.0 0.00 0.00
2021-12-14 Doyle Anthony officer: Chief Financial Officer 164,000.0 A-Award A 164,000.0 11.43 1,874,520.00
2021-12-14 Doyle Anthony officer: Chief Financial Officer 208,719.0 A-Award A 115,000.0 0.00 0.00
2021-12-14 Sheridan William P officer: Chief Medical Officer 164,000.0 A-Award A 164,000.0 11.43 1,874,520.00
2021-12-14 Sheridan William P officer: Chief Medical Officer 50,791.0 A-Award A 35,000.0 0.00 0.00
2021-12-14 Stonehouse Jon P director, officer: President & CEO 574,500.0 A-Award A 574,500.0 11.43 6,566,535.00
2021-12-14 Stonehouse Jon P director, officer: President & CEO 901,602.0 A-Award A 123,000.0 0.00 0.00
2021-12-07 Babu Yarlagadda S officer: Chief Discovery Officer 0.0 M-Exempt D 62,000.0 4.73 293,260.00
2021-12-07 Babu Yarlagadda S officer: Chief Discovery Officer 215,056.0 S-Sale D 30,100.0 12.20 367,220.00
2021-12-07 Babu Yarlagadda S officer: Chief Discovery Officer 245,156.0 M-Exempt A 62,000.0 4.73 293,260.00
2021-11-30 ASELAGE STEVE director 32,858.0 A-Award A 414.0 12.06 4,992.84
2021-11-30 HEGGIE THERESA director 15,623.0 A-Award A 829.0 12.06 9,997.74
2021-11-30 LEVIN ALAN G director 1,457.0 A-Award A 829.0 12.06 9,997.74
2021-11-30 INGRAM ROBERT ALEXANDER director 78,932.0 A-Award A 1,554.0 12.06 18,741.24
2021-11-24 MILANO VINCENT director 17,500.0 P-Purchase A 7,500.0 12.19 91,425.00
2021-11-23 Doyle Anthony officer: Chief Financial Officer 93,719.0 P-Purchase A 35,258.0 12.48 440,019.84
2021-11-15 ABERCROMBIE GEORGE B director 10,000.0 M-Exempt D 5,000.0 3.32 16,600.00
2021-11-15 ABERCROMBIE GEORGE B director 0.0 S-Sale D 5,000.0 12.27 61,350.00
2021-11-15 ABERCROMBIE GEORGE B director 5,000.0 M-Exempt A 5,000.0 3.32 16,600.00
2021-10-15 Hutson Nancy J director 0.0 M-Exempt D 30,000.0 3.22 96,600.00
2021-10-15 Hutson Nancy J director 65,073.0 S-Sale D 105,000.0 15.40 1,617,000.00
2021-10-15 Hutson Nancy J director 170,073.0 M-Exempt A 30,000.0 3.22 96,600.00
2021-10-15 Hutson Nancy J director 140,073.0 M-Exempt A 15,000.0 1.71 25,650.00
2021-10-15 Hutson Nancy J director 125,073.0 M-Exempt A 30,000.0 5.13 153,900.00
2021-10-15 Hutson Nancy J director 95,073.0 M-Exempt A 30,000.0 2.91 87,300.00
2021-09-20 McKee Amy E director 53,333.0 A-Award A 53,333.0 15.02 801,061.66
2021-09-15 ABERCROMBIE GEORGE B director 5,000.0 M-Exempt A 5,000.0 2.63 13,150.00
2021-09-15 ABERCROMBIE GEORGE B director 0.0 M-Exempt D 5,000.0 15.06 75,300.00
2021-09-15 ABERCROMBIE GEORGE B director 0.0 S-Sale D 5,000.0 2.63 13,150.00
2021-09-15 ABERCROMBIE GEORGE B director 5,000.0 S-Sale A 5,000.0 2.63 13,150.00
2021-09-13 LEE KENNETH B JR director 30,252.0 M-Exempt A 15,000.0 3.32 49,800.00
2021-09-13 LEE KENNETH B JR director 24,252.0 M-Exempt D 6,000.0 15.35 92,100.00
2021-09-13 LEE KENNETH B JR director 24,252.0 S-Sale D 6,000.0 3.32 19,920.00
2021-09-13 LEE KENNETH B JR director 30,252.0 S-Sale A 15,000.0 3.22 48,300.00
2021-09-13 LEE KENNETH B JR director 0.0 M-Exempt D 15,000.0 3.32 49,800.00
2021-09-10 ABERCROMBIE GEORGE B director 14,000.0 M-Exempt A 11,000.0 1.71 18,810.00
2021-09-10 ABERCROMBIE GEORGE B director 0.0 M-Exempt D 74,000.0 15.09 1,116,660.00
2021-09-10 ABERCROMBIE GEORGE B director 74,000.0 S-Sale A 30,000.0 2.91 87,300.00
2021-09-10 ABERCROMBIE GEORGE B director 44,000.0 S-Sale A 30,000.0 3.22 96,600.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.